marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
STRATA Skin Sciences Balance Sheet 2011-2024 | SSKN
Annual Balance Sheet STRATA Skin Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.4 M | -4.95 M | -801 K | 537 K | -9.09 M | 6.53 M | 19.9 M | 18 M | -6.43 M | -3.78 M | -7.86 M | -28 M |
Long Term Debt |
7.48 M | 7.32 M | 1.05 M | - | 7.14 M | 7.85 M | 21.8 M | 21 M | 5 M | - | - | - |
Long Term Debt Current |
355 K | 318 K | 369 K | 313 K | 252 K | 2.39 M | 1.71 M | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 2.05 M | 1.26 M | 7.64 M | 8.71 M | 22.3 M | 28.2 M | 5.11 M | 184 K | 275 K | 138 K |
Total Current Liabilities |
13.4 M | 12.8 M | 18.8 M | 17.4 M | 8.62 M | 7.67 M | 6.13 M | 7.08 M | 2.69 M | 5.65 M | 3.02 M | 1.45 M |
Total Liabilities |
30.4 M | 21.2 M | 20.9 M | 18.7 M | 16.3 M | 16.4 M | 28.5 M | 35.3 M | 7.79 M | 5.84 M | 3.29 M | 1.59 M |
Deferred Revenue |
2.78 M | 3.28 M | 2.26 M | 2.83 M | 2.1 M | 291 K | 235 K | 173 K | 43 K | 244 K | 172 K | - |
Retained Earnings |
-227 M | -222 M | -219 M | -215 M | -211 M | -229 M | -211 M | -207 M | -182 M | -168 M | -142 M | -120 M |
Total Assets |
52.3 M | 46.6 M | 46.8 M | 47.3 M | 47.5 M | 38.6 M | 43.2 M | 51.4 M | 20.1 M | 14.1 M | 17.3 M | 31.4 M |
Cash and Cash Equivalents |
5.43 M | 12.6 M | 10.6 M | 8.13 M | 16.5 M | 4.07 M | 3.93 M | 3.3 M | 11.4 M | 3.78 M | 7.86 M | 28 M |
Book Value |
21.8 M | 25.4 M | 25.9 M | 28.7 M | 31.2 M | 22.2 M | 14.7 M | 16.1 M | 12.3 M | 8.3 M | 14 M | 29.8 M |
Total Shareholders Equity |
21.8 M | 25.4 M | 25.9 M | 28.7 M | 31.2 M | 19.9 M | 14.7 M | 16.1 M | 12.3 M | 8.3 M | 14 M | 29.8 M |
All numbers in USD currency
Quarterly Balance Sheet STRATA Skin Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
15.1 M | 15.1 M | 15 M | 15 M | 15 M | 7.52 M | 7.48 M | 7.44 M | 7.4 M | 7.36 M | 7.32 M | 7.28 M | 497 K | 717 K | 1.05 M | 1.05 M | 1.05 M | 1.05 M | - | - | - | 6.42 M | 7.14 M | 7.14 M | 7.14 M | 7.14 M | 7.85 M | 7.85 M | 7.85 M | 7.85 M | 9.75 M | 9.75 M | 9.75 M | 9.75 M | 9.85 M | 9.85 M | 9.85 M | 9.85 M | - | 5.03 M | - | - | - | - | 6 M | - | 6 M | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.79 M | 5.11 M | 5.14 M | 115 K | 139 K | 184 K | 184 K | 184 K | 184 K | 276 K | 275 K | 275 K | 275 K | 138 K | 138 K | 138 K | 138 K |
Total Liabilities |
30.1 M | 30.6 M | 29.3 M | 31 M | 38.3 M | 29.8 M | 30.4 M | 31.4 M | 31.2 M | 31.3 M | 21.2 M | 20.6 M | 19.1 M | 21.7 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 19.3 M | 16.4 M | 16.4 M | 16.4 M | 28.2 M | 28.5 M | 28.5 M | 28.5 M | 34 M | 34 M | 34 M | 34 M | 7.79 M | 7.79 M | 7.79 M | 7.79 M | 5.84 M | 5.84 M | 5.84 M | 5.84 M | 3.3 M | 3.29 M | 3.29 M | 3.29 M | 1.59 M | 1.59 M | 1.59 M | 1.59 M |
Deferred Revenue |
2.26 M | 2.37 M | 2.12 M | 2.38 M | 2.44 M | 2.55 M | 2.78 M | 2.97 M | 3.25 M | 3.12 M | 3.28 M | 3.77 M | 2.38 M | 2.21 M | 2.26 M | 2.26 M | 2.26 M | 2.26 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 2.1 M | 2.1 M | 2.1 M | 440 K | 291 K | 350 K | 413 K | 334 K | 235 K | 235 K | 235 K | 235 K | 173 K | 173 K | 173 K | 173 K | 43 K | 43 K | 43 K | 42.8 K | 244 K | 244 K | 244 K | 244 K | 172 K | 172 K | 172 K | 172 K | - | - | - | - |
Retained Earnings |
-242 M | -241 M | -238 M | -234 M | -233 M | -230 M | -227 M | -227 M | -226 M | -224 M | -222 M | -221 M | -220 M | -221 M | -219 M | -219 M | -219 M | -219 M | -215 M | -215 M | -215 M | -215 M | -211 M | -211 M | -211 M | -211 M | -204 M | -229 M | -229 M | -229 M | -182 M | -211 M | -211 M | -211 M | -207 M | -207 M | -207 M | -207 M | -182 M | -182 M | -182 M | -182 M | -168 M | -168 M | -168 M | -168 M | -142 M | -142 M | -142 M | -142 M | -120 M | -120 M | -120 M | -120 M |
Total Assets |
39.6 M | 40 M | 42 M | 47.2 M | 55.2 M | 49.1 M | 52.3 M | 53.2 M | 53.6 M | 55.1 M | 46.6 M | 46.8 M | 44.9 M | 45.9 M | 46.8 M | 46.8 M | 46.8 M | 46.8 M | 47.3 M | 47.3 M | 47.3 M | 47.3 M | 47.5 M | 47.5 M | 47.5 M | 47.5 M | 39.1 M | 38.6 M | 38.6 M | 38.6 M | 43.2 M | 43.2 M | 43.2 M | 43.2 M | 50.1 M | 50.1 M | 50.1 M | 50.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M |
Cash and Cash Equivalents |
5.48 M | 5.24 M | 6.78 M | 7.13 M | 9.03 M | 2.82 M | 5.43 M | 7.45 M | 10 M | 10.9 M | 12.6 M | 13 M | 9.58 M | 10 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 8.13 M | 8.13 M | 8.13 M | 8.13 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 3.93 M | 3.93 M | 3.93 M | 3.93 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 3.78 M | 3.78 M | 3.78 M | 3.78 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | 28 M | 28 M | 28 M | 28 M |
Book Value |
9.5 M | 9.43 M | 12.7 M | 16.2 M | 16.9 M | 19.3 M | 21.8 M | 21.8 M | 22.3 M | 23.8 M | 25.4 M | 26.2 M | 25.8 M | 24.1 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M | 31.2 M | 31.2 M | 31.2 M | 31.2 M | 19.9 M | 22.2 M | 22.2 M | 22.2 M | 15 M | 14.7 M | 14.7 M | 14.7 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 8.3 M | 8.3 M | 8.3 M | 8.3 M | 14 M | 14 M | 14 M | 14 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M |
Total Shareholders Equity |
9.5 M | 9.43 M | 12.7 M | 16.2 M | 16.9 M | 19.3 M | 21.8 M | 21.8 M | 22.3 M | 23.8 M | 25.4 M | 26.2 M | 25.8 M | 24.1 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 28.7 M | 28.7 M | 28.7 M | 28.7 M | 31.2 M | 31.2 M | 31.2 M | 31.2 M | 19.9 M | 22.2 M | 22.2 M | 22.2 M | 15 M | 14.7 M | 14.7 M | 14.7 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 8.3 M | 8.3 M | 8.3 M | 8.3 M | 14 M | 14 M | 14 M | 14 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M |
All numbers in USD currency